GERON CORP Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- GERON CORP stock issued during period, value, issued for services for the quarter ending 2026-06-30 was $16.00K, a 38.46% decline year-over-year.
- GERON CORP stock issued during period, value, issued for services for the quarter ending 2026-03-31 was $13.00K, a 13.33% decline year-over-year.
- GERON CORP stock issued during period, value, issued for services for the quarter ending 2025-09-30 was $29.00K, a 107.14% increase year-over-year.
- GERON CORP stock issued during period, value, issued for services for the quarter ending 2025-06-30 was $26.00K, a 62.50% increase year-over-year.
- GERON CORP stock issued during period, value, issued for services for fiscal 2025 was $88.00K, a 34.33% decline from fiscal 2024.
- GERON CORP stock issued during period, value, issued for services for fiscal 2024 was $134.00K, a 83.84% decline from fiscal 2023.
- GERON CORP stock issued during period, value, issued for services for fiscal 2023 was $829.00K, a 214.02% increase from fiscal 2022.
- GERON CORP stock issued during period, value, issued for services for fiscal 2022 was $264.00K, a 190.11% increase from fiscal 2021.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2026-06-30 | $16.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $13.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $88.00K 10-K · filed 2026-03-02 | |
| 2025-09-30 | $29.00K 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $26.00K 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $15.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $134.00K 10-K · filed 2026-03-02 | |
| 2024-09-30 | $14.00K 10-Q · filed 2025-11-07 | |
| 2024-06-30 | $16.00K 10-Q · filed 2025-11-07 | |
| 2024-03-31 | $92.00K 10-Q · filed 2025-11-07 | |
| 2023-12-31 | $829.00K 10-K · filed 2026-03-02 | |
| 2023-09-30 | $28.31M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $99.00K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $112.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $264.00K 10-K · filed 2025-02-27 | |
| 2022-09-30 | $112.00K 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $13.00K 10-Q · filed 2023-11-02 | |
| 2022-03-31 | $15.00K 10-Q · filed 2023-11-02 | |
| 2021-12-31 | $91.00K 10-K · filed 2024-02-28 | |
| 2021-09-30 | $23.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $23.00K 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $25.00K 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $85.00K 10-K · filed 2023-03-16 | |
| 2019-12-31 | $68.00K 10-K · filed 2022-03-10 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-11 | $69.00K 10-K · filed 2015-03-11 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | |
| 2011-12-31 | -$210.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $41.00K 10-K · filed 2014-03-17 |
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | |
| 2010-12-31 | $3.10M 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |